Issue 3/2018
Content (25 Articles)
Meta-analysis of randomized clinical trials in the era of individual patient data sharing
Takuya Kawahara, Musashi Fukuda, Koji Oba, Junichi Sakamoto, Marc Buyse
Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update
Hiroki Nagai, Manabu Muto
A systematic review of publications on charged particle therapy for hepatocellular carcinoma
Hiroshi Igaki, Masashi Mizumoto, Toshiyuki Okumura, Kiyoshi Hasegawa, Norihiro Kokudo, Hideyuki Sakurai
Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis
Nobuaki Hoshino, Riki Ganeko, Koya Hida, Yoshiharu Sakai
Incidence, risk and prognostic role of anti-epidermal growth factor receptor-induced skin rash in biliary cancer: a meta-analysis
Fangqiang Wei, Donghun Shin, Xiujun Cai
The clinical features of squamous cell lung carcinoma with sensitive EGFR mutations
Yuri Taniguchi, Yoko Matsumoto, Ryutaro Furukawa, Sayaka Ohara, Kazuhiro Usui
A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma
Yi Xia, Yun-hai Li, Yun Chen, Qi Liu, Jun-hua Zhang, Jia-ying Deng, Ta-shan Ai, Han-ting Zhu, Harun Badakhshi, Kuai-Le Zhao
A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma
Shuji Hiramoto, Ken Kato, Hirokazu Shoji, Natsuko Okita, Atsuo Takashima, Yoshitaka Honma, Satoru Iwasa, Tetsuya Hamaguchi, Yasuhide Yamada, Yasuhiro Shimada, Narikazu Boku
Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands
Johannes J. M. Kwakman, G. Vink, J. H. Vestjens, L. V. Beerepoot, J. W. de Groot, R. L. Jansen, F. L. Opdam, H. Boot, G. J. Creemers, J. M. van Rooijen, M. Los, A. J. E. Vulink, H. Schut, E. van Meerten, A. Baars, P. Hamberg, E. Kapiteijn, D. W. Sommeijer, C. J. A. Punt, M. Koopman
Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type RAS gene: the JACCRO CC-14 study
Hironaga Satake, Akihito Tsuji, Masato Nakamura, Masaaki Ogawa, Takeshi Kotake, Yukimasa Hatachi, Hisateru Yasui, Akinori Takagane, Yoshihiro Okita, Kumi Nakamura, Toshihide Onikubo, Masahiro Takeuchi, Masashi Fujii
Characteristics of MUTYH variants in Japanese colorectal polyposis patients
Misato Takao, Tatsuro Yamaguchi, Hidetaka Eguchi, Yuhki Tada, Masakazu Kohda, Koichi Koizumi, Shin-ichiro Horiguchi, Yasushi Okazaki, Hideyuki Ishida
Differences in histological features and PD-L1 expression between sporadic microsatellite instability and Lynch-syndrome-associated disease in Japanese patients with colorectal cancer
Rin Yamada, Tatsuro Yamaguchi, Takeru Iijima, Rika Wakaume, Misato Takao, Koichi Koizumi, Tsunekazu Hishima, Shin-ichiro Horiguchi
Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study
Kanane Shimada, Koji Matsumoto, Takashi Mimura, Tetsuya Ishikawa, Jiro Munechika, Yoshimitsu Ohgiya, Miki Kushima, Yusuke Hirose, Yuka Asami, Chiaki Iitsuka, Shingo Miyamoto, Mamiko Onuki, Hajime Tsunoda, Ryu Matsuoka, Kiyotake Ichizuka, Akihiko Sekizawa
A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB–IIA cervical cancer
Xiuzhen Xie, Kun Song, Baoxia Cui, Jie Jiang, Xingsheng Yang, Beihua Kong
Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer
Akihiko Wakayama, Wataru Kudaka, Hirofumi Matsumoto, Hajime Aoyama, Takuma Ooyama, Yusuke Taira, Yoshihisa Arakaki, Yuko Shimoji, Tadaharu Nakasone, Kumiko Nishihira, Itomi Kaneshima, Tomoko Tamaki, Naoki Yoshimi, Yoichi Aoki
Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy
Hironori Fukuda, Toshio Takagi, Tsunenori Kondo, Kazuhiko Yoshida, Satoru Shimizu, Yoji Nagashima, Kazunari Tanabe
Effect of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: an evaluation based on tumor density
Takashi Hatano, Mahito Atsuta, Hiroyuki Inaba, Katsuhisa Endo, Shin Egawa
Oncological outcomes after cytoreductive nephrectomy for patients with metastatic renal cell carcinoma with inferior vena caval tumor thrombus
Hideaki Miyake, Takayuki Sugiyama, Ryota Aki, Yuto Matsushita, Keita Tamura, Daisuke Motoyama, Toshiki Ito, Atsushi Otsuka
Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy
Hiroki Ishihara, Toshio Takagi, Tsunenori Kondo, Hidekazu Tachibana, Kazuhiko Yoshida, Kenji Omae, Junpei Iizuka, Hirohito Kobayashi, Kazunari Tanabe
Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan
Shuichi Morizane, Masashi Honda, Satoshi Fukasawa, Atsushi Komaru, Junichi Inokuchi, Masatoshi Eto, Masaki Shimbo, Kazunori Hattori, Yoshiaki Kawano, Atsushi Takenaka
No significant impact of response to prior androgen receptor-axis-targeted agents on the efficacy of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer
Hideaki Miyake, Yuto Matsushita, Keita Tamura, Daisuke Motoyama, Toshiki Ito, Takayuki Sugiyama, Atsushi Otsuka
Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate
Akiyuki Yamamoto, Masashi Kato, Hirotaka Matsui, Ryo Ishida, Tohru Kimura, Yasuhito Funahashi, Naoto Sassa, Yoshihisa Matsukawa, Osamu Kamihira, Ryohei Hattori, Momokazu Gotoh, Toyonori Tsuzuki
Prognostic factors in Chinese patients with prostate cancer receiving primary androgen deprivation therapy: validation of Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score and impacts of pre-existing obesity and diabetes mellitus
Meng-Bo Hu, Tian Yang, Ji-Meng Hu, Wen-Hui Zhu, Hao-Wen Jiang, Qiang Ding